Analysis of the key themes driving M&A activity reveals that digitalization accounted for 14 pharmaceutical deals announced in Q4 2023, worth a total value of $24.1m. The $11m acquisition of Digital Diagnostics by Kingsway Financial Services was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, digitalization-related deal activity increased by 2913% in Q4 2023 compared with the previous quarter’s total of $0.8m and fell by 51% as compared to Q4 2022. Related deal volume increased by 133% in Q4 2023 versus the previous quarter.
The top-ranked financial advisors supporting these M&A deals in Q4 2023 were Alantra Partners; Macquarie Group; VIII Capital with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q4 2023 were Wilson Sonsini Goodrich & Rosati Professional; Chammas & Marcheteau; Clark Wilson with 2, 1, 1 deals respectively.
See Also:
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.